Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Morbidity in Elderly Patients Undergoing Surgery for Fractured Neck of Femur: Plasma vs Ocplex for Warfarin Reversal
2006-005206-31Phase 3Terminated
- Sponsor
- University Hospital Örebro
- Start
- Dec 2006
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of balfaxar in Neck Of Femur Fracture (2 arms), sponsored by University Hospital Örebro. Primary endpoint: All-cause morbidity within 30 days. Started Dec 2006; status: terminated.
02
Drugs
balfaxar
03
Conditions
Neck Of Femur Fracture
Beyond the preview
Go deeper on 2006-005206-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005206-31.